Vitamin E Supplements in Treating Patients Undergoing Surgery for Colorectal Cancer
Completed · Phase 1
Conditions studied: Colorectal Cancer
In brief
RATIONALE: Vitamin E may help prevent the development of cancer. Studying samples of tissue from patients with colorectal cancer who receive Vitamin E before undergoing surgery in the laboratory may help doctors learn more about how Vitamin E changes biomarkers related to colorectal cancer. PURPOSE: This randomized early phase I trial is studying giving vitamin E supplements to see how it affects biomarkers in patients undergoing surgery for colorectal cancer.
Key facts
- Study ID
- NCT00905918
- Run by
- Rutgers, The State University of New Jersey
- People needed
- 14
- Starts
- 2009-06-01
- Expected to finish
- 2014-05-01
- Last updated by the study team
- 2014-09-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.